Advocacy intelligence hub — real-time data for patient organizations
Memorial Sloan Kettering Cancer Center — PHASE2
Haihe Biopharma Co., Ltd. — PHASE1, PHASE2
Kantonsspital Winterthur KSW
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Tazverik
Epizyme, Inc.
Tazverik
(tazemetostat)Orphan drugacceleratedEpizyme, Inc.
12.1 Mechanism of Action Tazemetostat is an inhibitor of the methyltransferase, EZH2, and some EZH2 gain-of-function mutations including Y646X, A682G,...
Xing Zhang
Sun Yat-Sen University Cancer Center
📍 PAOLI, PA
Robert Maki, MD, PhD, MD, PhD
Memorial Sloan Kettering Cancer Center
📍 PHILADELPHIA, PA
Scott Schuetze, MD, PhD, MD, PhD
University of Michigan
📍 ANN ARBOR, MI
Suzanne Forrest, MD
Dana-Farber Cancer Institute
Sandip P Patel
SWOG Cancer Research Network
📍 Birmingham, Alabama
Ciara Kelly, MBBCh BAO
Memorial Sloan Kettering Cancer Center